Thompson Davis & Co., Inc. Chembio Diagnostics, Inc. Transaction History
Thompson Davis & Co., Inc.
- $112 Million
- Q2 2024
About CHEMBIO DIAGNOSTICS, INC.
- Ticker CEMI
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,224,600
- Description
- Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...